Harvey Morgan - CryoLife Independent Director

Director

Mr. Harvey Morgan is an Independent Director of CryoLife, Inc., He has more than 40 years of investment banking experience, with significant expertise in strategic advisory services, mergers and acquisitions, private placements, and underwritings. He served as a Managing Director of the investment banking firm Bentley Associates, L.P. from 2004 to December 31, 2012, and from 2001 to 2004 he was a Principal of Shattuck Hammond Partners, an independent investment banking and financial advisory firm. Mr. Morgan also served on the Board of Directors of Family Dollar Stores, Inc., a leading operator of discount variety stores, which was acquired by Dollar Tree Inc. in 2014, and Cybex International, Inc., a leading manufacturer of premium exercise equipment since 2008.
Age 78
Tenure 16 years
Professional MarksMBA
Phone770 426-0031
Webwww.Artivion.com
Morgan received his undergraduate degree from the University of North Carolina at Chapel Hill and an MBA from the Harvard Business School. The Board of Directors has determined that Mr. Morgan should serve as a director of CryoLife because of his past business experience, particularly with respect to investment banking and capital markets.

CryoLife Management Efficiency

The company has Return on Asset of 1.01 % which means that on every $100 spent on assets, it made $1.01 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.57 %, implying that it generated $0.57 on every 100 dollars invested. CryoLife's management efficiency ratios could be used to measure how well CryoLife manages its routine affairs as well as how well it operates its assets and liabilities.
CryoLife has 363.37 M in debt with debt to equity (D/E) ratio of 1.17, which is OK given its current industry classification. CryoLife has a current ratio of 4.13, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for CryoLife to invest in growth at high rates of return.

Similar Executives

Showing other executives

DIRECTOR Age

John ConnorsNike Inc
61
Alan GrafNike Inc
66
Pablo LavinCompania Cervecerias Unidas
61
Rodrigo KirbergCompania Cervecerias Unidas
54
Frank FallwellSNDL Inc
N/A
Rory CullinanCompania Cervecerias Unidas
60
Vittorio LioiCompania Cervecerias Unidas
77
John RogersNike Inc
62
Amelia VarelaSteven Madden
52
Hemmo ParsonCompania Cervecerias Unidas
51
Travis KnightNike Inc
46
Thasunda DuckettNike Inc
47
Cathleen BenkoNike Inc
62
Timothy CookNike Inc
60
Patricia MillerVera Bradley
86
Elizabeth ComstockNike Inc
59
Jose MackennaCompania Cervecerias Unidas
63
Michelle PelusoNike Inc
48
Jose WesterflierCompania Cervecerias Unidas
56
Peter HenryNike Inc
51
CryoLife, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia. Cryolife operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 1200 people. CryoLife (CRY) is traded on New York Stock Exchange in USA and employs 1,200 people.

Management Performance

CryoLife Leadership Team

Elected by the shareholders, the CryoLife's board of directors comprises two types of representatives: CryoLife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CryoLife. The board's role is to monitor CryoLife's management team and ensure that shareholders' interests are well served. CryoLife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CryoLife's outside directors are responsible for providing unbiased perspectives on the board's policies.
James Mackin, Chairman of the Board, President, Chief Executive Officer, Director
Anthony Semedo, Independent Director
Daniel Bevevino, Independent Director
Dennis Maier, Vice President - Operations
Ronald McCall, Presiding Independent Director
Thomas Bogenschutz, Senior Vice President - EMEA, General Manager - Hechingen
Jeffrey Burbank, Independent Director
Jon Salveson, Independent Director
Jean Holloway, Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
Thomas Ackerman, Independent Director
F Barthold, Vice President - Research and Development
Harvey Morgan, Independent Director
Amy Horton, Chief Accounting Officer, Vice President
Scott Capps, Vice President - Clinical Research
Marna Borgstrom, Independent Director
Michael Simpson, Senior Vice President - Regulatory Affairs and Quality Assurance
John Davis, Senior Vice President - Global Sales and Marketing
James Bullock, Independent Director
Matthew Getz, Vice President - Human Resources
D Lee, Chief Financial Officer, Chief Operating Officer, Executive Vice President

CryoLife Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CryoLife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Consideration for investing in CryoLife Stock

If you are still planning to invest in CryoLife check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CryoLife's history and understand the potential risks before investing.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios